We are the Emerging Viral Pathogens Lab, headed by Dr Shashank Tripathi (@Shashank_IISc) at the Centre for Infectious Disease Research (CIDR) at @iiscbangalore
Members of @evp_iisc are glad to be part of the upcoming GLOBAL-BIO INDIA 2023 meet in Pragati Maidan, New Delhi, from December 4-6th 2023. Looking forward to meeting startups, Pharma companies, and researchers at our stall (Booth No. F77)@BIRAC_2012
Pleased to share this study from @evp_iisc on innate immune antagonism by SARS-CoV-2. Published in Cellular And Molecular Life Sciences @SpringerCellBio. Kudos to @OyahidaK leading this. https://t.co/enBXkbeqg2
#Molecular Virology 2023 at @IISc: 2 days of high-quality Virology, sourced from about 50 institutions across India. Congratulations to all the winners. Thanks to all the participants and sponsors. @India_Alliance@JNCASR@THSTIFaridabad . The next one in IAV TVM, Kerala.
We have extended the registration deadline to 25th August. Abstract submission is mandatory fro registration. For more details visit
https://t.co/5nyvSBbVA2
Online now: Picolinic acid is a broad-spectrum inhibitor of enveloped virus entry that restricts SARS-CoV-2 and influenza A virus in vivo https://t.co/1u473cUwc4
Glad to share this study on broad spectrum antiviral, led by Rohan Narayan in @evp_iisc, now published in Cell Reports Medicine. Thanks to @BIRAC_2012 and @India_Alliance for funding. https://t.co/gfOtvKMPCj
New study by @evp_iisc@Shashank_IISc shows how several mutations accumulated through recombination in #SARSCoV2 viral proteins, allows the Omicron variants to escape from the host’s defenses and bind more tightly to the host cell. https://t.co/DzhMvuXRe8
#IIScresearch
Our research article reporting enhanced recombination in SARS-CoV-2 Omicron variants, its potential cause and consequences is now published in the Journal of Medical Virology. Full credit to Rishad in our lab.
https://t.co/9oCRfEUZeN
Recombination mutation is on the rise in the SARS-CoV-2 virus. @Shashank_IISc is investigating the reasons behind this rise of recombinants
@shaastramag
https://t.co/GvOTJu9SL3
Glad to have contributed to this study @ScienceAdvances. It describes host factors that restrict or facilitate Flu infections across different hosts. Thanks to @India_Alliance for supporting @evp_iisc .
https://t.co/LCOoF6bGZD
Congratulations to my @evp_iisc colleague and Graduate student Rishad Shiraz on @SerbFicci PMRF award. He will be working in collaboration with @GennovaBio on developing mRNA vaccine against Respiratory viruses.
In this preprint we report important observation of increased recombination in Omicron SARS-CoV-2 and its potential role in antibody escape.
https://t.co/C65kkTGrKS